Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Paramdeep S Bilkhu, Shehzad A Naroo & James S Wolffsohn. (2015) Treatment of ocular allergies: nonpharmacologic, pharmacologic and immunotherapy. Expert Review of Ophthalmology 10:3, pages 257-266.
Read now
Read now
Erminia Ridolo, Marcello Montagni, Marco Caminati, Gianenrico Senna, Cristoforo Incorvaia & Giorgio Walter Canonica. (2014) Emerging drugs for allergic conjunctivitis. Expert Opinion on Emerging Drugs 19:2, pages 291-302.
Read now
Read now
Tuba Celik & Elif Betul Turkoglu. (2014) Comparative Evaluation of Olopatadine 0.01% Combined Fluorometholone 0.1% Treatment Versus Olopatadine 0.01% Combined Ketorolac 0.4% Treatment in Patients with Acute Seasonal Allergic Conjunctivitis. Current Eye Research 39:1, pages 42-46.
Read now
Read now
Annabelle C Gallois-Bernos & Robin L Thurmond. (2012) Alcaftadine, a new antihistamine with combined antagonist activity at histamine H1, H2, and H4 receptors. Journal of Receptor, Ligand and Channel Research 5, pages 9-20.
Read now
Read now
Andrea Leonardi & Luigi Quintieri. (2010) Olopatadine: a drug for allergic conjunctivitis targeting the mast cell. Expert Opinion on Pharmacotherapy 11:6, pages 969-981.
Read now
Read now
Andrea Leonardi & Bob Lanier. (2008) Urban eye allergy syndrome: a new clinical entity?. Current Medical Research and Opinion 24:8, pages 2295-2302.
Read now
Read now
Andrea Leonardi. (2007) New drug treatments for ocular allergies. Expert Review of Ophthalmology 2:3, pages 397-408.
Read now
Read now
Articles from other publishers (30)
Mathias Roth, Katharina Schröder, Klara Charlotte Borgardts, Uwe Pleyer & Gerd Geerling. 2023. Die Augenheilkunde. Die Augenheilkunde
1
8
.
José Alvaro P. Gomes, Dimitri T. Azar, Christophe Baudouin, Etty Bitton, Wei Chen, Farhad Hafezi, Pedram Hamrah, Ruth E. Hogg, Jutta Horwath-Winter, Georgios A. Kontadakis, Jodhbir S. Mehta, Elisabeth M. Messmer, Victor L. Perez, David Zadok & Mark D.P. Willcox. (2023) TFOS Lifestyle: Impact of elective medications and procedures on the ocular surface. The Ocular Surface 29, pages 331-385.
Crossref
Crossref
Anne M. Salapatek, Nina Werkhäuser, Basma Ismail, Ralph Mösges, Esther Raskopf & Andreas Bilstein. (2021) Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis. Clinical and Translational Allergy 11:1.
Crossref
Crossref
DeGaulle I. Chigbu, Pooja Jain & Zafar K. Khan. 2020. Advanced Concepts in Human Immunology: Prospects for Disease Control. Advanced Concepts in Human Immunology: Prospects for Disease Control
229
277
.
Christine Purslow. (2016) Managing ocular symptoms of hay fever – simple can be effective. Optician 2016:7, pages 142883-1.
Crossref
Crossref
NikhilS Gokhale. (2016) Systematic approach to managing vernal keratoconjunctivitis in clinical practice: Severity grading system and a treatment algorithm. Indian Journal of Ophthalmology 64:2, pages 145.
Crossref
Crossref
Mayret Castillo, Neil W Scott, Mohammad Z Mustafa, Mohammed S Mustafa & Augusto Azuara-Blanco. (2015) Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis. Cochrane Database of Systematic Reviews 2015:6.
Crossref
Crossref
C. Bucolo, C.B.M. Platania, F. Drago & S. Salomone. 2015. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
B. Mortemousque, T. Bourcier, M. Khairallah, R. Messaoud, F. Brignole-Baudouin, D. Renault, H. Rebika & D. Brémond-Gignac. (2014) Comparison of preservative-free ketotifen fumarate and preserved olopatadine hydrochloride eye drops in the treatment of moderate to severe seasonal allergic conjunctivitis. Journal Français d'Ophtalmologie 37:1, pages 1-8.
Crossref
Crossref
Pradeep R. Jadhav, Vijay V. Moghe & Yeshwant A. Deshmukh. (2013) Drug Utilization Study in Ophthalmology Outpatients at a Tertiary Care Teaching Hospital. ISRN Pharmacology 2013, pages 1-5.
Crossref
Crossref
Flavio MantelliVirginia L. CalderStefano Bonini. (2013) The Anti-Inflammatory Effects of Therapies for Ocular Allergy. Journal of Ocular Pharmacology and Therapeutics 29:9, pages 786-793.
Crossref
Crossref
Kelvin Ho-Nam Wan, Li Jia Chen, Shi Song Rong, Chi Pui Pang & Alvin L. Young. (2013) Topical Cyclosporine in the Treatment of?Allergic Conjunctivitis. Ophthalmology 120:11, pages 2197-2203.
Crossref
Crossref
Kevin P. Cusack, Vikram G. Kalthod, Rajarathnam E. Reddy & Sanjay R. Chemburkar. 2012. Bioactive Heterocyclic Compound Classes. Bioactive Heterocyclic Compound Classes
289
312
.
Lan Gong, Xinghuai Sun, Jia Qu, Lili Wang, Mingzhi Zhang, Hong Zhang, Linnong Wang, Yangshun Gu, Albert Elion-Mboussa, Lipika Roy & Byron Zhu. (2012) Loteprednol Etabonate Suspension 0.2% Administered QID Compared With Olopatadine Solution 0.1% Administered BID in the Treatment of Seasonal Allergic Conjunctivitis: A Multicenter, Randomized, Investigator-Masked, Parallel Group Study in Chinese Patients. Clinical Therapeutics 34:6, pages 1259-1272.e1.
Crossref
Crossref
Paramdeep S. Bilkhu, James S. Wolffsohn & Shehzad A. Naroo. (2012) A review of non-pharmacological and pharmacological management of seasonal and perennial allergic conjunctivitis. Contact Lens and Anterior Eye 35:1, pages 9-16.
Crossref
Crossref
Mohammed S Mustafa, Mayret Castillo, Mohammed Z Mustafa, Neil Scott & Augusto Azuara-Blanco. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Jon I. WilliamsKathryn S. KennedyJames A. GowGail L. TorkildsenMark B. AbelsonPaul J. GomesTimothy R. McNamara, for the Bepotastine Besil. (2011) Prolonged Effectiveness of Bepotastine Besilate Ophthalmic Solution for the Treatment of Ocular Symptoms of Allergic Conjunctivitis. Journal of Ocular Pharmacology and Therapeutics 27:4, pages 385-393.
Crossref
Crossref
F. Mantelli, A. Lambiase, S. Bonini & S. Bonini. (2011) Clinical trials in allergic conjunctivits: a systematic review. Allergy 66:7, pages 919-924.
Crossref
Crossref
Mark B. Abelson, James T. McLaughlin & Paul J. Gomes. (2011) Antihistamines in Ocular Allergy: Are They All Created Equal?. Current Allergy and Asthma Reports 11:3, pages 205-211.
Crossref
Crossref
Divya Seth & Farah I. Khan. (2011) Causes and Management of Red Eye in Pediatric Ophthalmology. Current Allergy and Asthma Reports 11:3, pages 212-219.
Crossref
Crossref
DeGaulle I. Chigbu & Shanthy Sandrasekaramudaly-Brown. (2011) Ocular surface disease: A case of vernal keratoconjunctivitis. Contact Lens and Anterior Eye 34:1, pages 39-44.
Crossref
Crossref
Brett Bielory & Leonard Bielory. (2010) Atopic Dermatitis and Keratoconjunctivitis. Immunology and Allergy Clinics of North America 30:3, pages 323-336.
Crossref
Crossref
DeGaulle I. Chigbu. (2009) The management of allergic eye diseases in primary eye care. Contact Lens and Anterior Eye 32:6, pages 260-272.
Crossref
Crossref
Alessandro Lambiase, Alessandra Micera & Stefano Bonini. (2009) Multiple action agents and the eye: do they really stabilize mast cells?. Current Opinion in Allergy & Clinical Immunology 9:5, pages 454-465.
Crossref
Crossref
De Gaulle I. Chigbu. (2009) The pathophysiology of ocular allergy: A review. Contact Lens and Anterior Eye 32:1, pages 3-15.
Crossref
Crossref
A Leonardi, L Motterle & M Bortolotti. (2008) Allergy and the eye. Clinical and Experimental Immunology 153:Supplement_1, pages 17-21.
Crossref
Crossref
JOHN M. YANNI & NEAL P. BARNEY. 2008. Ocular Therapeutics. Ocular Therapeutics
239
274
.
Carlo GelmettiS. Bonini, E. Galli & A. Lambiase. 2008. La pratica dell’atopia. La pratica dell’atopia
145
148
.
Margarita Calonge & José M Herreras. (2007) Clinical grading of atopic keratoconjunctivitis. Current Opinion in Allergy & Clinical Immunology 7:5, pages 442-445.
Crossref
Crossref
Andrea Leonardi. 2007. Uveitis and Immunological Disorders. Uveitis and Immunological Disorders
25
43
.